Opus Genetics, Inc. (IRD) — Institutional Holders, Q2 2026 (page 2)
103 institutional investment managers reported a IRD position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $236.4M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 103. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IRD 13F holders ranked 101–103 of 103
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | FMR#101 · 142 sh | 142 | $584.00 | 0.00% | +1675.0% |
| 102 | Caitong International Asset Management , Ltd#102 · 63 sh | 63 | $259.00 | 0.00% | New |
| 103 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#103 · 737 sh | 737 | — | — | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.